Alnylam Pharmaceuticals, ALNY:
1. In previous Williams edge stock meetings it was noted that Alnylam pharmaceuticals could be bought upon any confirmed breakout above $80 for a forecast advance to $87/$89. Partial exits were instructed to be taken at/near $83.50.
2. Today’s (Mon., Oct. 13) session broke out on the upside above $80 and completed the run to the $87/$89 upside target (session high, $87.95, so far).
3. Some remaining position should be held for the possibility of higher prices beyond $89. Will update as the market continues to confirm.